A Randomized Phase II/III Study of Dalotuzumab in...

  • Main
  • A Randomized Phase II/III Study of...

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer

F. Sclafani, T. Y. Kim, D. Cunningham, T. W. Kim, J. Tabernero, H. J. Schmoll, J. K. Roh, S. Y. Kim, Y. S. Park, T. K. Guren, E. Hawkes, S. J. Clarke, D. Ferry, J. Frödin, M. Ayers, M. Nebozhyn, C. Pe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Year:
2015
Language:
english
DOI:
10.1093/jnci/djv258
File:
PDF, 822 KB
english, 2015
Conversion to is in progress
Conversion to is failed